Sleep Well,
Live Well

Circadin® - Prolonged-release melatonin

Circadin® 2mg 1

Circadin®, prolonged-release melatonin 2mg, is an innovative sleep medication, first in a new class of drugs: melatonin receptor agonists. Circadin® is a prescription only drug, approved for treatment of primary insomnia in many countries globally.

Melatonin is an important hormone which is produced in one’s body during the night hours. It has many important functions as a signal to the internal biological clock in one’s brain, thereby allowing the adjustment of biological functions such as sleep, blood pressure and certain hormones with the night period. Melatonin production is inhibited by light and is diminished with advancing age and in some medical conditions.

  • News & Views

    • Dr. Zach Pearl Staff

    • November, 2022
    • Circadian Rhythm Sleep Disorders
    • Read More

Circadin®, a novel prolonged release formulation, is able to mimic the internal melatonin secretion profile by releasing melatonin gradually over 8-10 hours from the time it’s is being swallowed.

In well controlled clinical trials in thousands of insomnia patients, Circadin® has been proven to help patients to fall asleep easily and have a good night sleep, allowing them to wake-up feeling refreshed and ready for the next day.

Circadin® is the first sleep agent to demonstrate improvements in next day functioning and Quality of Life and is the only licensed medication containing melatonin.

Because of its proven efficacy and long term safety Circadin® is the only sleep drug approved for treatment for up to 13 weeks, without being restricted to several days as other insomnia drugs.

Want to hear more about Circadin®? click here!